Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.
2.

Charge and Polarity Preferences for N-Glycosylation: A Genome-Wide In Silico Study and Its Implications Regarding Constitutive Proliferation and Adhesion of Carcinoma Cells.

Manwar Hussain MR, Iqbal Z, Qazi WM, Hoessli DC.

Front Oncol. 2018 Feb 28;8:29. doi: 10.3389/fonc.2018.00029. eCollection 2018.

3.

N-acetylgalactosaminyltransferases in cancer.

Hussain MR, Hoessli DC, Fang M.

Oncotarget. 2016 Aug 16;7(33):54067-54081. doi: 10.18632/oncotarget.10042. Review.

4.

Mechanistic understanding and significance of small peptides interaction with MHC class II molecules for therapeutic applications.

Afridi S, Hoessli DC, Hameed MW.

Immunol Rev. 2016 Jul;272(1):151-68. doi: 10.1111/imr.12435. Review.

PMID:
27319349
5.

BRAF gene: From human cancers to developmental syndromes.

Hussain MR, Baig M, Mohamoud HS, Ulhaq Z, Hoessli DC, Khogeer GS, Al-Sayed RR, Al-Aama JY.

Saudi J Biol Sci. 2015 Jul;22(4):359-73. doi: 10.1016/j.sjbs.2014.10.002. Epub 2014 Oct 23. Review.

6.

Exploring the sequence context of phosphorylatable amino acids: the contribution of the upgraded MAPRes tool.

Iqbal Z, Hoessli DC, Qazi WM, Ahmad M, Shakoori AR, Nasir-ud-Din.

J Cell Biochem. 2015 Mar;116(3):370-9. doi: 10.1002/jcb.24983.

PMID:
25258092
7.

Influence of the sequence environment and properties of neighboring amino acids on amino-acetylation: relevance for structure-function analysis.

Iqbal Z, Hoessli DC, Kaleem A, Munir J, Saleem M, Afzal I, Shakoori AR, Nasir-Ud-Din.

J Cell Biochem. 2013 Apr;114(4):874-87. doi: 10.1002/jcb.24426.

PMID:
23097243
8.
9.

O-GlcNAc modification of the anti-malarial vaccine candidate PfAMA1: in silico-defined structural changes and potential to generate a better vaccine.

Uddin N, Hoessli DC, Butt A, Kaleem A, Iqbal Z, Afzal I, Muhammad Hammad, Zamani Z, Shakoori AR.

Mol Biol Rep. 2012 Apr;39(4):4663-72. doi: 10.1007/s11033-011-1258-4. Epub 2011 Oct 22.

PMID:
22020851
10.

CREB in long-term potentiation in hippocampus: role of post-translational modifications-studies In silico.

Kaleem A, Hoessli DC, Haq IU, Walker-Nasir E, Butt A, Iqbal Z, Zamani Z, Shakoori AR; Nasir-ud-Din.

J Cell Biochem. 2011 Jan;112(1):138-46. doi: 10.1002/jcb.22909.

PMID:
21053365
11.

Membrane-associated signaling in human B-lymphoma lines.

Tauzin S, Ding H, Burdevet D, Borisch B, Hoessli DC.

Exp Cell Res. 2011 Jan 15;317(2):151-62. doi: 10.1016/j.yexcr.2010.09.011. Epub 2010 Sep 25.

PMID:
20875408
12.

The sphingolipid-rich rafts of ALK+ lymphomas downregulate the Lyn-Cbp/PAG signalosome.

Yerly S, Ding H, Tauzin S, van Echten-Deckert G, Borisch B, Hoessli DC.

Eur J Haematol. 2010 Aug;85(2):93-8. doi: 10.1111/j.1600-0609.2010.01492.x. Epub 2010 Jun 18.

PMID:
20561033
13.

The function of GluR1 and GluR2 in cerebellar and hippocampal LTP and LTD is regulated by interplay of phosphorylation and O-GlcNAc modification.

Din N, Ahmad I, Ul Haq I, Elahi S, Hoessli DC, Shakoori AR.

J Cell Biochem. 2010 Feb 15;109(3):585-97. doi: 10.1002/jcb.22436.

PMID:
20052678
14.

Effect on the Ras/Raf signaling pathway of post-translational modifications of neurofibromin: in silico study of protein modification responsible for regulatory pathways.

Nasir-ud-Din, Kaleem A, Ahmad I, Walker-Nasir E, Hoessli DC, Shakoori AR.

J Cell Biochem. 2009 Nov 1;108(4):816-24. doi: 10.1002/jcb.22301.

PMID:
19718661
15.

Phosphoproteome sequence analysis and significance: mining association patterns around phosphorylation sites utilizing MAPRes.

Ahmad I, Mehmood A, Khurshid A, Qazi WM, Hoessli DC, Walker-Nasir E, Shakoori AR; Nasir-ud-Din.

J Cell Biochem. 2009 Sep 1;108(1):64-74. doi: 10.1002/jcb.22220.

PMID:
19544398
16.

Phytochemicals as modulators of neoplastic phenotypes.

Ding H, Tauzin S, Hoessli DC.

Pathobiology. 2009;76(2):55-63. doi: 10.1159/000201674. Epub 2009 Apr 9. Review.

17.

MAPRes: Mining association patterns among preferred amino acid residues in the vicinity of amino acids targeted for post-translational modifications.

Ahmad I, Qazi WM, Khurshid A, Ahmad M, Hoessli DC, Khawaja I, Choudhary MI, Shakoori AR; Nasir-ud-Din.

Proteomics. 2008 May;8(10):1954-8. doi: 10.1002/pmic.200700657.

PMID:
18491291
18.

Epidermal growth factor receptors: function modulation by phosphorylation and glycosylation interplay.

Kaleem A, Ahmad I, Hoessli DC, Walker-Nasir E, Saleem M, Shakoori AR, Nasir-Ud-Din.

Mol Biol Rep. 2009 Apr;36(4):631-9. doi: 10.1007/s11033-008-9223-6. Epub 2008 Mar 14.

PMID:
18340549
19.

In silico modulation of HMGN-1 binding to histones and gene expression by interplay of phosphorylation and O-GlcNAc modification.

Ahmad I, Khan TS, Hoessli DC, Walker-Nasir E, Kaleem A, Shakoori AR, Nasir-ud-Din.

Protein Pept Lett. 2008;15(2):193-9.

PMID:
18289110
20.

MAPRes: an efficient method to analyze protein sequence around post-translational modification sites.

Ahmad I, Hoessli DC, Qazi WM, Khurshid A, Mehmood A, Walker-Nasir E, Ahmad M, Shakoori AR; Nasir-ud-Din.

J Cell Biochem. 2008 Jul 1;104(4):1220-31. doi: 10.1002/jcb.21699.

PMID:
18286469
21.

Oncogenic association of the Cbp/PAG adaptor protein with the Lyn tyrosine kinase in human B-NHL rafts.

Tauzin S, Ding H, Khatib K, Ahmad I, Burdevet D, van Echten-Deckert G, Lindquist JA, Schraven B, Din NU, Borisch B, Hoessli DC.

Blood. 2008 Feb 15;111(4):2310-20. Epub 2007 Dec 10.

22.

Immediate-early gene regulation by interplay between different post-translational modifications on human histone H3.

Kaleem A, Hoessli DC, Ahmad I, Walker-Nasir E, Nasim A, Shakoori AR, Nasir-ud-Din.

J Cell Biochem. 2008 Feb 15;103(3):835-51.

PMID:
17668447
23.

In silico modulation of apoptotic Bcl-2 proteins by mistletoe lectin-1: functional consequences of protein modifications.

Khwaja TA, Wajahat T, Ahmad I, Hoessli DC, Walker-Nasir E, Kaleem A, Qazi WM, Shakoori AR, Din NU.

J Cell Biochem. 2008 Feb 1;103(2):479-91.

PMID:
17583555
24.

In silico determination of intracellular glycosylation and phosphorylation sites in human selectins: implications for biological function.

Ahmad I, Hoessli DC, Gupta R, Walker-Nasir E, Rafik SM, Choudhary MI, Shakoori AR; Nasir-ud-Din.

J Cell Biochem. 2007 Apr 15;100(6):1558-72.

PMID:
17230456
25.

Phosphorylation and glycosylation interplay: protein modifications at hydroxy amino acids and prediction of signaling functions of the human beta3 integrin family.

Ahmad I, Hoessli DC, Walker-Nasir E, Choudhary MI, Rafik SM, Shakoori AR; Nasir-ud-Din.

J Cell Biochem. 2006 Oct 15;99(3):706-18.

PMID:
16676352
26.

Oct-2 DNA binding transcription factor: functional consequences of phosphorylation and glycosylation.

Ahmad I, Hoessli DC, Walker-Nasir E, Rafik SM, Shakoori AR, Nasir-ud-Din.

Nucleic Acids Res. 2006 Jan 8;34(1):175-84. Print 2006.

27.

Mycobacterial lipoarabinomannans modulate cytokine production in human T helper cells by interfering with raft/microdomain signalling.

Shabaana AK, Kulangara K, Semac I, Parel Y, Ilangumaran S, Dharmalingam K, Chizzolini C, Hoessli DC.

Cell Mol Life Sci. 2005 Jan;62(2):179-87.

PMID:
15666089
28.

Role of sialic acid and sulfate groups in cervical mucus physiological functions: study of Macaca radiata glycoproteins.

Nasir-ud-Din, Hoessli DC, Rungger-Brändle E, Hussain SA, Walker-Nasir E.

Biochim Biophys Acta. 2003 Oct 13;1623(2-3):53-61.

PMID:
14572902
29.

ALK-positive anaplastic large-cell lymphoma: strong T and B anti-tumour responses may cause hypocellular aspects of lymph nodes mimicking inflammatory lesions.

Borisch B, Yerly S, Cerato Ch, Schwaller J, Wacker P, Ozsahin AH, Brousse N, Hoessli DC.

Eur J Haematol. 2003 Oct;71(4):243-9.

PMID:
12950232
30.

Plasmodium falciparum merozoite surface protein 1.

Hoessli DC, Poincelet M, Gupta R, Ilangumaran S, Nasir-ud-Din.

Eur J Biochem. 2003 Jan;270(2):366-75.

31.

Anti-CD20 therapeutic antibody rituximab modifies the functional organization of rafts/microdomains of B lymphoma cells.

Semac I, Palomba C, Kulangara K, Klages N, van Echten-Deckert G, Borisch B, Hoessli DC.

Cancer Res. 2003 Jan 15;63(2):534-40.

32.

HIV-1 entry into T-cells is not dependent on CD4 and CCR5 localization to sphingolipid-enriched, detergent-resistant, raft membrane domains.

Percherancier Y, Lagane B, Planchenault T, Staropoli I, Altmeyer R, Virelizier JL, Arenzana-Seisdedos F, Hoessli DC, Bachelerie F.

J Biol Chem. 2003 Jan 31;278(5):3153-61. Epub 2002 Nov 12.

33.

Anti-CD20 treatments and the lymphocyte membrane: pathology for therapy.

Borisch B, Semac I, Soltermann A, Palomba C, Hoessli DC.

Verh Dtsch Ges Pathol. 2001;85:161-6.

PMID:
11894393
34.

Cytokine profiles in paraffin-embedded biopsy samples of lepromatous leprosy patients: semi-quantitative measure of cytokine mRNA using RT-PCR.

Shabaana AK, Venkatasubramani R, Narayan NS, Hoessli DC, Dharmalingam K.

Int J Lepr Other Mycobact Dis. 2001 Sep;69(3):204-14.

PMID:
11875764
35.

Signaling through sphingolipid microdomains of the plasma membrane: the concept of signaling platform.

Hoessli DC, Ilangumaran S, Soltermann A, Robinson PJ, Borisch B, Nasir-Ud-Din.

Glycoconj J. 2000 Mar-Apr;17(3 -4):191-7. Review.

PMID:
11201790
36.

Microdomains in lymphocyte signalling: beyond GPI-anchored proteins.

Ilangumaran S, He HT, Hoessli DC.

Immunol Today. 2000 Jan;21(1):2-7. Review. No abstract available.

PMID:
10637551
37.

Signal transduction via CD44: role of plasma membrane microdomains.

Ilangumaran S, Borisch B, Hoessli DC.

Leuk Lymphoma. 1999 Nov;35(5-6):455-69. Review.

PMID:
10609783
38.

Microdomain-dependent regulation of Lck and Fyn protein-tyrosine kinases in T lymphocyte plasma membranes.

Ilangumaran S, Arni S, van Echten-Deckert G, Borisch B, Hoessli DC.

Mol Biol Cell. 1999 Apr;10(4):891-905.

39.
40.

GPI-anchors and cell membranes: a special relationship.

Hoessli DC, Robinson PJ.

Trends Cell Biol. 1998 Feb;8(2):87-9. Review. No abstract available.

PMID:
9695815
42.

Carbohydrate moiety of Plasmodium falciparum glycoproteins: the nature of the carbohydrate-peptide linkage in the MSP-2 glycoprotein.

Khan AH, Qazi AM, Hoessli DC, Torred-Duarte AP, Senaldi G, Qazi MH, Walker-Nasir E, Nasir-ud-Din.

Biochem Mol Biol Int. 1997 Oct;43(3):655-68.

PMID:
9352084
44.

Differential regulation of Src-family protein tyrosine kinases in GPI domains of T lymphocyte plasma membranes.

Arni S, Ilangumaran S, van Echten-Deckert G, Sandhoff K, Poincelet M, Briol A, Rungger-Brändle E, Hoessli DC.

Biochem Biophys Res Commun. 1996 Aug 23;225(3):801-7.

PMID:
8780693
45.
46.

Transfer of exogenous glycosylphos-phatidylinositol (GPI)-linked molecules to plasma membranes.

Ilangumaran S, Robinson PJ, Hoessli DC.

Trends Cell Biol. 1996 May;6(5):163-7.

PMID:
15157464
47.

Requirement of Lyn and Syk tyrosine kinases for the prevention of apoptosis by cytokines in human eosinophils.

Yousefi S, Hoessli DC, Blaser K, Mills GB, Simon HU.

J Exp Med. 1996 Apr 1;183(4):1407-14.

48.
49.

Glycobiology of Plasmodium falciparum: an emerging area of research.

Hoessli DC, Davidson EA, Schwarz RT, Nasir-ud-Din.

Glycoconj J. 1996 Feb;13(1):1-3. Review. No abstract available.

PMID:
8785480
50.

Integration of mycobacterial lipoarabinomannans into glycosylphosphatidylinositol-rich domains of lymphomonocytic cell plasma membranes.

Ilangumaran S, Arni S, Poincelet M, Theler JM, Brennan PJ, Nasir-ud-Din, Hoessli DC.

J Immunol. 1995 Aug 1;155(3):1334-42.

PMID:
7636199

Supplemental Content

Loading ...
Support Center